[5] |
Joss N, Staatz C E, Thomson A H, et al. Predictors of new onset diabetes after renal transplantation[J]. Clin Transplant ,2007, 19:136-143.
|
[1] |
Montori V M, Basu A, Erwin P J, et al. Posttransplantation diabetes: a systematic review of the literature[J]. Diabetes Care ,2002, 25:583-592.
|
[6] |
Hjelmesth J,Sagedal S,Hartmann A,et al.Cytomegalovirus infection is associated with increased risk for new-onset diabetes and impaired insulin release after renal transplantation[J]. Diabetologia,2004,10:1007/s00125-004-1499-z.
|
[2] |
Miles A M V,Sumrani N,Horowitz R,et al.Diabetes mellitus after renal.transplantation[J]. Transplantation, 1998,65: 380.
|
[7] |
Knobler H, Stagnaro-Green A, Wallenstein S, et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C[J]. J Clin Gastroenterol, 1998,26: 30-33.
|
[8] |
Baid S,Cosimi A B,Farrell M L,et al.Post-transplant diabetes mellitus in liver transplant recipients:Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation,2001,72: 1066-1072.
|
[3] |
Baid S,Cosimi A B,Farrell M L,et al.Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with Hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation ,2001,72: 1066.
|
[9] |
Bloom R D, Rao V, Weng F, et al. Association of hepatitis C with post-transplant diabetes in renal transplant patients on tacrolimus[J]. J Am Soc Nephrol,2002, 13:1374-1380.
|
[4] |
Shah T,Kasravi A,Huang E, et al.Risk factors for development of new-onset diabetes mellitus after transplantation[J]. Transplantation, 2006, 82:1673-1676.
|
[10] |
Khalili M,Lim J W,Bass N,et al.New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection[J]. Liver Transpl,2004,10: 349-355.
|
[5] |
Joss N, Staatz C E, Thomson A H, et al. Predictors of new onset diabetes after renal transplantation[J]. Clin Transplant ,2007, 19:136-143.
|
[11] |
Vincenti F, Friman S, Scheuermann E, et al. On behalf of the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) Investigators: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transpl,2007, 7:1506-1514.
|
[6] |
Hjelmesth J,Sagedal S,Hartmann A,et al.Cytomegalovirus infection is associated with increased risk for new-onset diabetes and impaired insulin release after renal transplantation[J]. Diabetologia,2004,10:1007/s00125-004-1499-z.
|
[12] |
Panz V R, Bonegio R, Raal F J, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1[J]. Transplantation, 2002,73(4):587-590.
|
[7] |
Knobler H, Stagnaro-Green A, Wallenstein S, et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C[J]. J Clin Gastroenterol, 1998,26: 30-33.
|
[8] |
Baid S,Cosimi A B,Farrell M L,et al.Post-transplant diabetes mellitus in liver transplant recipients:Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation,2001,72: 1066-1072.
|
[13] |
Midtvedt K,Hjelmesaeth J,Hartmann A,et al.Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal[J]. J Am Soc Nephrol ,2004, 15:3233-3239.
|
[14] |
Qing Yuan Li,Feng Li,Ji Hua Sun, et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models[J]. Immunopharmacology and Immunotoxicology, 2009,31(4): 675-681.
|
[9] |
Bloom R D, Rao V, Weng F, et al. Association of hepatitis C with post-transplant diabetes in renal transplant patients on tacrolimus[J]. J Am Soc Nephrol,2002, 13:1374-1380.
|
[10] |
Khalili M,Lim J W,Bass N,et al.New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection[J]. Liver Transpl,2004,10: 349-355.
|
[15] |
Plaumann S,Blume R. Activation of the dual-leucine-zipper- bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A[J]. Mol Pharmacol, 2008,73(3):652-659.
|
[11] |
Vincenti F, Friman S, Scheuermann E, et al. On behalf of the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) Investigators: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transpl,2007, 7:1506-1514.
|
[16] |
Drachenberg C B, Klassen D K, Weir M R,et al.Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation[J]. Transplantation,1999,68:396-402.
|
[17] |
滕雅芹,牛玉坚,徐 春,等.他克莫司对大鼠血糖的影响及其作用机制[J].中国实验动物学报,2012,20(2):74-77.
|
[12] |
Panz V R, Bonegio R, Raal F J, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1[J]. Transplantation, 2002,73(4):587-590.
|
[18] |
Oetjen E,Baun D,Beimesche S,et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63: 1289-1295.
|
[13] |
Midtvedt K,Hjelmesaeth J,Hartmann A,et al.Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal[J]. J Am Soc Nephrol ,2004, 15:3233-3239.
|
[14] |
Qing Yuan Li,Feng Li,Ji Hua Sun, et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models[J]. Immunopharmacology and Immunotoxicology, 2009,31(4): 675-681.
|
[19] |
王金海, 梁廷波. FK-506对大鼠肝细胞膜胰岛素受体影响的研究[J]. 临床外科杂志, 2006, 14(5):291-293.
|
[15] |
Plaumann S,Blume R. Activation of the dual-leucine-zipper- bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A[J]. Mol Pharmacol, 2008,73(3):652-659.
|
[20] |
安 军,徐 春,牛玉坚,等.他克莫司和环孢素A对大鼠升血糖作用的比较[J].武警医学,2012,23(9):776-779.
|
[16] |
Drachenberg C B, Klassen D K, Weir M R,et al.Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation[J]. Transplantation,1999,68:396-402.
|
[17] |
滕雅芹,牛玉坚,徐 春,等.他克莫司对大鼠血糖的影响及其作用机制[J].中国实验动物学报,2012,20(2):74-77.
|
[21] |
Davidson J, Wilkinson A, Dantal J, et al. International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an International Expert Panel meeting[J]. Transplantation ,2003, 75(Suppl 10):S3-S24.
|
[18] |
Oetjen E,Baun D,Beimesche S,et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63: 1289-1295.
|
[22] |
Luan F L, Steffi ck D E, Gadegbeku C, et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression[J]. Am J Transplant ,2009, 9:160-168.
|
[23] |
Ghisdal L, Bouchta N B, Broeders N, et al. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature[J]. Transpl Int, 2008, 21:146-151.
|
[19] |
王金海, 梁廷波. FK-506对大鼠肝细胞膜胰岛素受体影响的研究[J]. 临床外科杂志, 2006, 14(5):291-293.
|
[20] |
安 军,徐 春,牛玉坚,等.他克莫司和环孢素A对大鼠升血糖作用的比较[J].武警医学,2012,23(9):776-779.
|
[24] |
王文君,徐 春,牛玉坚,等.肝移植术后胰岛素敏感性和胰岛β细胞功能的改变[J].中国糖尿病杂志,2012,20(2) :133-135.
|
[25] |
Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia[J]. Transplantation,2008, 85:353-358.
|
[21] |
Davidson J, Wilkinson A, Dantal J, et al. International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an International Expert Panel meeting[J]. Transplantation ,2003, 75(Suppl 10):S3-S24.
|
[22] |
Luan F L, Steffi ck D E, Gadegbeku C, et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression[J]. Am J Transplant ,2009, 9:160-168.
|
[26] |
Kurian B,Joshi R,Helmuth A.Effectiveness and longterm safety of thiazolidinediones and metformin in renal transplant recipients[J]. Endocrinol Pract, 2008, 14:979-984.
|
[23] |
Ghisdal L, Bouchta N B, Broeders N, et al. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature[J]. Transpl Int, 2008, 21:146-151.
|
[27] |
Türk T, Pietruck F, Dolff S, et al. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation[J]. Am J Transplant,2006, 6:842-846.
|
[28] |
牛玉坚,王宏宇,徐 春,等.肝移植后糖代谢的紊乱的治疗方法和效果[J].中华营养杂志,2012,20(4):200-203.
|
[24] |
王文君,徐 春,牛玉坚,等.肝移植术后胰岛素敏感性和胰岛β细胞功能的改变[J].中国糖尿病杂志,2012,20(2) :133-135.
|
[29] |
Shen Z Y, Niu Y J,Xu C, et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus[J]. Clinical Laboratory, 2013,59:869-874.
|
[25] |
Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia[J]. Transplantation,2008, 85:353-358.
|
[26] |
Kurian B,Joshi R,Helmuth A.Effectiveness and longterm safety of thiazolidinediones and metformin in renal transplant recipients[J]. Endocrinol Pract, 2008, 14:979-984.
|
[27] |
Türk T, Pietruck F, Dolff S, et al. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation[J]. Am J Transplant,2006, 6:842-846.
|
[28] |
牛玉坚,王宏宇,徐 春,等.肝移植后糖代谢的紊乱的治疗方法和效果[J].中华营养杂志,2012,20(4):200-203.
|
[29] |
Shen Z Y, Niu Y J,Xu C, et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus[J]. Clinical Laboratory, 2013,59:869-874.
|
|
|